Literature DB >> 15015600

Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line.

Paolo Marchetti1, Domenico A P Galla, F Paola Russo, Enrico Ricevuto, Vincenzo Flati, Giampiero Porzio, Corrado Ficorella, M Grazia Cifone.   

Abstract

BACKGROUND: Oxaliplatin (L-OHP), active in a wide range of human and animal tumours, also CDDP-resistant, possesses unique molecular characteristics of action. However, the mechanisms by which the damage induced by L-OHP triggers a death signal are not yet fully defined.
MATERIALS AND METHODS: After L-OHP treatment of the HCT15 human colon cancer cell line, apoptosis was evaluated by DNA laddering detection and by flow cytometry; the effect on specific caspase-3, -8 and -9 inhibitors, mitochondrial membrane permeability transition, cytochrome C release and expression of CD95 and CD95L were also assessed.
RESULTS: HCT15 cells underwent apoptosis when treated with all used drug concentrations (7-25 microM). Treatment of cells with L-OHP resulted in the activation of caspase-8, -9 and -3, in a mitochondrial membrane depolarisation, and in an increase of CD95 receptor and CD95 ligand levels.
CONCLUSION: The results correlated well with the ability of L-OHP to induce apoptosis and give further insights into the mechanisms underlying the L-OHP-induced apoptosis of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15015600

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Combined effects of anticancer drugs and new synthetic α-methylene-δ-lactones on MCF-7 cells.

Authors:  Katarzyna Gach; Jacek Szymański; Dorota Pomorska; Angelika Długosz; Jakub Modranka; Tomasz Janecki; Anna Janecka
Journal:  Tumour Biol       Date:  2015-03-06

2.  Clinical and experimental study of oxaliplatin in treating human gastric carcinoma.

Authors:  Wan-Long Lin; Ding-Guo Li; Qiang Chen; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

3.  Oxaliplatin with biweekly low dose leucovorin and bolus and continuous infusion of 5-fluorouracil (modified FOLFOX 4) as a salvage therapy for patients with advanced gastric cancer.

Authors:  Sung-Hwan Suh; Hyuk-Chan Kwon; Ji-Hoon Jo; Young-Rak Cho; Bong-Gun Seo; Dong-Mee Lee; Sung-Hyun Kim; Jae-Seok Kim; Hyo-Jin Kim
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

4.  Efficacy and safety of oxaliplatin, 5-Fluorouracil, and folinic Acid combination chemotherapy as first-line treatment in metastatic or recurrent gastric cancer.

Authors:  Han Jo Kim; Jun Young Eun; Young Woo Jeon; Jina Yun; Kyoung Ha Kim; Se Hyung Kim; Hyun Jung Kim; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Nam Su Lee; Kyu Taek Lee; Seong-Kyu Park; Jong-Ho Won; Dae Sik Hong; Hee Sook Park
Journal:  Cancer Res Treat       Date:  2011-09-30       Impact factor: 4.679

5.  Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance.

Authors:  Ye Zhang; Longchang Huang; Haoze Shi; Hang Chen; Jianxin Tao; Renhui Shen; Tong Wang
Journal:  Cancer Sci       Date:  2017-11-18       Impact factor: 6.716

6.  Cytochrome c: Using Biological Insight toward Engineering an Optimized Anticancer Biodrug.

Authors:  Louis J Delinois; Omar De León-Vélez; Adriana Vázquez-Medina; Alondra Vélez-Cabrera; Amanda Marrero-Sánchez; Christopher Nieves-Escobar; Daniela Alfonso-Cano; Delvin Caraballo-Rodríguez; Jael Rodriguez-Ortiz; Jemily Acosta-Mercado; Josué A Benjamín-Rivera; Kiara González-González; Kysha Fernández-Adorno; Lisby Santiago-Pagán; Rafael Delgado-Vergara; Xaiomy Torres-Ávila; Andrea Maser-Figueroa; Gladimarys Grajales-Avilés; Glorimar I Miranda Méndez; Javier Santiago-Pagán; Miguel Nieves-Santiago; Vanessa Álvarez-Carrillo; Kai Griebenow; Arthur D Tinoco
Journal:  Inorganics (Basel)       Date:  2021-11-16

7.  Autophagy protects against oxaliplatin-induced cell death via ER stress and ROS in Caco-2 cells.

Authors:  Yan Shi; Bin Tang; Pei-Wu Yu; Bo Tang; Ying-Xue Hao; Xiao Lei; Hua-Xing Luo; Dong-Zhu Zeng
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.

Authors:  D Arango; A J Wilson; Q Shi; G A Corner; M J Arañes; C Nicholas; M Lesser; J M Mariadason; L H Augenlicht
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.